Tag - Visus

Developments

Visus posts positive Phase 3 results in presbyopia

Visus Therapeutics reported that the BRIO-I Phase 3 clinical trial met its primary and secondary endpoints, evaluating the safety and efficacy of BRIMOCHOL PF, a preservative-free ophthalmic solution for the treatment...

May 5, 2023

Developments

Visus posts positive Phase 3 data to treat presbyopia

Visus Therapeutics reported positive topline results from its Phase 3 pivotal BRIO-I trial, demonstrating highly statistically significant improvements in near and distance binocular visual acuity at multiple...

April 20, 2023

Tag - Visus

Visus posts positive Phase 3 results in presbyopia

Visus posts positive Phase 3 data to treat presbyopia

General

More